Risperdal becomes the most prescribed antipsychotic medication in the U.S., with sales topping $2 billion, despite a “black box” warning being added to the drug’s label regarding use on the elderly population.
2005 – Risperdal becomes most prescribed antipsychotic in U.S.
Announcement Date: January 1, 2005